Boyu Capital, according to a Bloomberg report, is set to acquire Quasar, a Hong Kong-based medical device company. The acquisition deal is valued at over USD 600 million, reflecting Quasar’s current market capitalization. The transaction is anticipated to close imminently, with the support of Quasar’s extensive healthcare clients globally.
Quasar’s Global Presence and Workforce
Quasar employs a workforce of 1500 people and has established a strong global footprint with manufacturing facilities in China and Thailand, as well as offices in the US and Israel. This acquisition by Boyu Capital will further expand the reach and capabilities of Quasar within the medical device industry.-Fineline Info & Tech
